Agreement Format Sample Clauses

Agreement Format. All words used herein in the singular form shall extend to and include the plural. All words used in the plural form shall extend to and include the singular. All words used in any gender shall extend to and include all genders.
AutoNDA by SimpleDocs
Agreement Format. In the agreement, specify the responsibilities of each party. The agreement should contain the following items plus any additional items applicable to the project: 1. Identify the railroad name, LPA name, and MFT section number, if applicable. For Federal-aid projects, also identify the project and job number. 2. Include a description of the work to be done. 3. Provide a location description and location map. Include the AAR DOT number and the railroad milepost. 4. For projects with federal funds, include a statement that the project is subject to FHWA requirements. 5. Identify who is responsible for the surveys, plan preparation, specifications, and estimates. 6. Include the responsibilities for special signal and pavement markings at railroad crossings. 7. Identify which agency is responsible for letting and awarding the contract and who will provide construction supervision of the work. 8. Identify the selected method of construction (e.g., State or local let contract, railroad or local forces). 9. Note if concurrence in the award of the contract is required. 10. Provide a division of cost showing funding responsibilities and the type of funds being used. 11. Identify the method of payment and/or reimbursement by each party. 12. Note the LPA appropriation for their share of the cost. 13. For federally funded projects, include any statements regarding DBEs. Note the DBE program being followed by the LPA if it is a locally let contract. 14. Identify who is responsible for railroad adjustments and the salvage of old equipment. 15. Identify who is responsible for maintenance of the completed work (e.g., crossing surfaces, warning signals, power lines, roadway approaches). 16. If protection work is involved, the agreement must stipulate that the work conforms to the ICC Requirements for Railroad-Highway Grade Crossing Protection and to the Illinois Manual on Uniform Traffic Control Devices (ILMUTCD). 17. Note who is responsible for the retention of records for inspections, audits, etc. As a minimum, railroads must retain records for three years after completion of the project. 18. Identify the proposed completion date of the project. 19. Provide provisions in the agreement to allow termination of the project. 20. Include a statement that IDOT audits railroad bills for work performed by railroad forces in accordance with FHWA requirements on all projects involving the use of State or federal funds.
Agreement Format. ‌ When a project requires a utility agreement, the LPA is normally responsible for its preparation and execution in consultation with the district. Each utility agreement must specify the responsibilities of each party and contain the following items plus any additional items applicable to the project: 1. Identify the utility name, LPA name, and MFT section number, if applicable. For Federal- aid projects, also identify the project and job number. 2. Include a description of the work to be done. 3. Provide a location description and location map. 4. For projects with federal funds, include a statement that the project is subject to FHWA requirements. 5. Identify who is responsible for the surveys, plan preparation, specifications, and estimates. 6. Identify which agency is responsible for letting and awarding the contract and who will provide construction supervision of the work. 7. Identify the selected method of construction (e.g., State- or local-let contract, utility forces, or contract by utility company). 8. Note if concurrence in the award of the contract is required. 9. Provide a division of cost showing funding responsibilities and the type of funds being used. 10. Identify the method of payment and/or reimbursement by each party. 11. Note the LPA appropriation for their share of the cost. 12. For federally funded projects, include any statements regarding DBEs. Note the DBE program being followed by the LPA, if it is a locally let contract. 13. Note who is responsible for the retention of records for inspections, audits, etc. As a minimum, the utility company must retain records for three years following completion of work. 14. Identify the proposed completion date of the project. 15. Provide provisions in the agreement to allow termination of the project. 16. Include a statement that IDOT will audit utility bills for work performed by utility forces in accordance with FHWA requirements on all projects involving the use of State or federal funds.
Agreement Format. The agreement should be assembled in the following order: 1. Part I - Agreement 2. Part II - General Provisions 3. Attachment A - Statement of Work 4. Attachment B - Program Budget Summary and Budget Detail 5. Attachment C - Performance/Progress Report Requirements 6. Attachment D - Financial Status Report 7. Attachment E - Other Program Specific Requirements (if applicable) 8. Attachment FAmerican Recovery and Reinvestment Act (ARRA) Requirements (if applicable, mandatory).
Agreement Format. A rental agreement is a legal document which lays out the prescribed terms and conditions under which the rented property is leased out that is to be followed between the land lord and the tenant. Though the relationship between the land lord and the tenant is cordial most of the time, it is good to have a written ...
Agreement Format. The section headings and captions of this Agreement are, and the arrangement of this Agreement is, for the sole convenience of the Parties. The section headings, captions, and arrangement of this Agreement do not in any way affect, limit, amplify, or modify the terms and provisions of this Agreement.
Agreement Format. The Lease Deed (Deed) is made and executed here in this the …….. day of , 2023 at Guwahati. M/S. …………………………. as company incorporated within the meaning of companies Act, 1956 having its registered office situated at …………………………….. in the district of …………. , being represented by, Shri / Smt hereinafter called “THE LESSOR” (Which term or expression shall unless excluded by or repugnant to the subject or context be deemed to mean and include its affiliates, subsidiaries, successor, and/or successors in interest and assigns) of the FIRST PART.
AutoNDA by SimpleDocs

Related to Agreement Format

  • Cooperation Agreement If a Cooperating Institution is appointed, the Fund shall enter into a Cooperation Agreement with the Cooperating Institution setting forth the terms and conditions of its appointment.

  • Transition Agreement In the event of termination of this Agreement in its entirety by AbbVie pursuant to Section 12.3.2 or by Galapagos pursuant to Section 12.2.1, or with respect to one (1) or more countries or other jurisdictions by AbbVie pursuant to Section 12.3 or by Galapagos pursuant to Section 12.2.2(i), Galapagos and AbbVie shall negotiate in good faith the terms and conditions of a written transition agreement (the “Transition Agreement”) pursuant to which AbbVie and Galapagos will effectuate and coordinate a smooth and efficient transition of relevant obligations and rights to Galapagos as reasonably necessary for Galapagos to exercise the licenses granted pursuant to Sections 12.6 or 12.7 after termination of this Agreement (in its entirety or with respect to one (1) or more countries or other jurisdictions, as applicable) as and to the extent set forth in this Article 12. For clarity, AbbVie shall not be required to Manufacture or have Manufactured the Molecules or Products by or on behalf of Galapagos as part of the Transition Agreement. 12.8.1 The Transition Agreement shall provide that in the event of a termination of this Agreement in its entirety by AbbVie pursuant to Section 12.3.2 or by Galapagos in its entirety pursuant to Section 12.2.1, AbbVie shall: (i) where permitted by Applicable Law, transfer to Galapagos all of its right, title, and interest in all Regulatory Documentation then Controlled by AbbVie or its Affiliates or Sublicensees and in its/their name applicable to the Products in the Territory that are the subject of an exclusive license grant in Section 12.6.1(iii); (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) if requested by Galapagos and unless expressly prohibited by any Regulatory Authority, transfer control to Galapagos of all Clinical Studies being Conducted by AbbVie or its Affiliates or Sublicensees as of the effective date of termination and continue to Conduct such Clinical Studies, at Galapagos’ cost, for up to […***…] ([…***…]) months to enable such transfer to be completed without interruption of any such Clinical Study; provided, that (a) Galapagos shall not have any obligation to continue any Clinical Study unless required by Applicable Law, and (b) with respect to each Clinical Study for which such transfer is expressly prohibited by the applicable Regulatory Authority, if any, AbbVie shall continue to Conduct such Clinical Study to completion, at Galapagos’ cost; and (iv) assign (or cause its Affiliates or Sublicensees to assign) to Galapagos all agreements with any Third Party with respect to the Conduct of pre-clinical Development activities, Clinical Studies or Manufacturing activities for the Products, including agreements with contract research organizations, clinical sites, and investigators, unless, with respect to any such agreement, (a) Galapagos declines such assignment, or (b) such agreement (1) expressly prohibits such assignment, in which case AbbVie shall cooperate with Galapagos in reasonable respects to secure the consent of the applicable Third Party to such assignment, or (2) covers products covered by Patents Controlled by AbbVie or any of its Affiliates in addition to the Products, in which case AbbVie shall, at Galapagos’ sole cost and expense, cooperate with Galapagos in all reasonable respects to facilitate the execution of a new agreement between Galapagos and the applicable Third Party. 12.8.2 The Transition Agreement shall provide that in the event of a termination of this Agreement with respect to a country or other jurisdiction by AbbVie pursuant to Section 12.3 or by Galapagos pursuant to Section 12.2.2(i) (but not in the case of any termination of this Agreement in its entirety), AbbVie shall: (i) where permitted by Applicable Law, transfer to Galapagos all of its right, title, and interest in all Regulatory Approvals owned by, or in the name of, AbbVie or its Affiliates or Sublicensees, which Regulatory Approvals are solely applicable to the relevant country or jurisdiction and the Products that are the subject of an exclusive license grant in Section 12.7, as such Regulatory Approvals exists as of the effective date of such termination of this Agreement with respect to such relevant country or jurisdiction; provided, that AbbVie retains a license and right of reference under any Regulatory Approval transferred pursuant to this clause as necessary or reasonably useful for AbbVie to Commercialize Products in the Territory, Develop Molecules or Products in support of such Commercialization, or Manufacture Molecules or Products in support of such Development or Commercialization; (ii) notify the applicable Regulatory Authorities and take any other action reasonably necessary to effect the transfer set forth in clause (i) above; (iii) grant Galapagos a right of reference to all Regulatory Documentation then owned by, or in the name of, AbbVie or its Affiliates or Sublicensees, and which Regulatory Documentation is not transferred to Galapagos pursuant to clause (i) above, and is necessary or reasonably useful for Galapagos, any of its Affiliates or sublicensees to Develop or Commercialize in the terminated country or jurisdiction the Product(s) that are the subject of the license grant in Section 12.7 as such Regulatory Documentation exists as of the effective date of such termination of this Agreement with respect to such terminated country or jurisdiction; (iv) if requested by Galapagos and unless expressly prohibited by any Regulatory Authority, transfer control to Galapagos of all Clinical Studies specific to such terminated country(ies) being Conducted by AbbVie or its Affiliates or Sublicensees as of the effective date of termination and continue to Conduct such Clinical Studies, at Galapagos’ cost, for up to […***…] ([…***…]) months to enable such transfer to be completed without interruption of any such Clinical Study; provided, that (a) Galapagos shall not have any obligation to continue any Clinical Study unless required by Applicable Law, and (b) with respect to each Clinical Study for which such transfer is expressly prohibited by the applicable Regulatory Authority, if any, AbbVie shall continue to Conduct such Clinical Study to completion, at Galapagos’ cost; and (v) assign (or cause its Affiliates or Sublicensees to assign) to Galapagos all agreements with any Third Party with respect to the Conduct of Clinical Studies specific to such terminated country(ies), including agreements with contract research organizations, clinical sites, and investigators, unless, with respect to any such agreement, (a) Galapagos declines such assignment, or (b) such agreement (1) expressly prohibits such assignment, in which case AbbVie shall cooperate with Galapagos in reasonable respects to secure the consent of the applicable Third Party to such assignment, or (2) covers products covered by Patents Controlled by AbbVie or any of its Affiliates in addition to the Products, in which case AbbVie shall, at Galapagos’ sole cost and expense, cooperate with Galapagos in all reasonable respects to facilitate the execution of a new agreement between Galapagos and the applicable Third Party.

  • Executed Agreement The Offerors shall have received from the Placement Agents an executed copy of this Agreement.

  • Printing Agreement Copies of this Agreement shall be printed with the expense shared equally between the Board and the Association within thirty (30) days after the Agreement is signed.

  • Certification Regarding Entire TIPS Agreement for Part 1 and Part 2 Contracts 5 This is a two part solicitation. Part 1 is solicited for TIPS sales that are not considered a "public work" construction (1) The TIPS solicitation document resulting in the Agreement; (2) Any addenda or clarifications issued in relation to the corresponding TIPS solicitation; (3) All solicitation information provided to Vendor by TIPS through the TIPS eBid System; (3) Vendor’s entire proposal response to the corresponding TIPS solicitation including all accepted required attachments, acknowledged notices and certifications, accepted negotiated terms, accepted pricing, accepted responses to questions, and accepted written clarifications of Vendor’s proposal, and; any properly included attachments to the TIPS Contract. Does Vendor agree? Yes, Vendor agrees TIPS Members often turn to TIPS Contracts for ease of use and to receive discounted pricing. Vendor must respond with a percentage from 0%-100%. The percentage discount that you input below will be applied to your Part 1 "Catalog Pricing", as defined in the solicitation, for all TIPS Sales made during the life of the contract. You cannot alter this percentage discount once the solicitation legally closes. You will always be required to discount every TIPS Sale by the percentage included below with the exception of limited goods/services specifically identified and excluded from this discount in Vendor’s original proposal. If you add goods or services to your "Catalog Pricing" during the life of the contract, you will be required to sell those new items with this discount applied.

  • Integrated Agreement This Agreement constitutes the entire understanding and agreement among the parties hereto with respect to the subject matter hereof, and there are no agreements, understandings, restrictions or warranties among the parties other than those set forth herein provided for.

  • Agreement Scope The scope of this Agreement is as prescribed in section 46 of the Act, setting out: • the health services to be provided to the State by the HSP, • the TTR in support of the health services to be provided, • the funding to be provided to the HSP for the provision of the health services, including the way in which the funding is to be provided, • the performance measures and operational targets for the provision of the health services by the HSP, • how the evaluation and review of results in relation to the performance measures and operational targets is to be carried out, • the performance data and other data to be provided by the HSP to the Department CEO, including how, and how often, the data is to be provided, and • any other matter the Department CEO considers relevant to the provision of the health services by the HSP. Where appropriate, reference will be made in this Agreement to Policy Frameworks issued by the Department CEO pursuant to Part 3, Division 2 of the Act.

  • Services Agreement “Services Agreement” shall mean any present or future agreements, either written or oral, between Covered Entity and Business Associate under which Business Associate provides services to Covered Entity which involve the use or disclosure of Protected Health Information. The Services Agreement is amended by and incorporates the terms of this BA Agreement.

  • Collaboration Agreement The Collaboration Agreement shall not have been terminated in accordance with its terms and shall be in full force and effect.

  • AGREEMENT FOR SALE There is an overlap in this list: use the descriptions that are most ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ .

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!